Skip to main content

BNP PARIBAS ARBITRAGE, SA

Position in BBIO — BridgeBio Pharma, Inc.

CIK 1166588 NEW YORK, NY

Position in BBIO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$86,057,320
-$11,013,569 QoQ
Shares Held
1,155,442
-11.6% QoQ
Ownership
0.591%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#42
of 473 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in BBIO Over Time

Shares Held

Position Value (USD)

Derivatives in BBIO

reported options exposure · as of Mar 31, 2024
CallValue
$1,020
CallShares
33
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

BNP PARIBAS ARBITRAGE, SA holds $3,331,911,027 across 414 Biotechnology names. BBIO ranks #8 (2.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
8 BBIO
BridgeBio Pharma, Inc.
This page
1,155,442 $86,057,320

All Filings in BBIO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $86,057,320 1,155,442
2026-03-31 $97,070,889 1,307,176
2025-12-31 $121,822,563 1,592,660
2025-09-30 $33,203,372 639,264
2025-06-30 $18,958,869 439,066
2025-03-31 $10,879,248 314,702
2024-12-31 $691,762 25,210
2024-09-30 $968,472 38,039
2024-06-30 $336,914 13,301
2024-03-31 $1,020 33
2024-03-31 $4,265,228 137,944
2023-12-31 $5,137,486 127,260
2023-09-30 $3,926,282 148,892
2023-06-30 $1,841,294 107,052
2023-03-31 $1,895,856 114,346
2022-12-31 $1,024,920 134,504
2022-06-30 $1,180,254 129,984
2022-03-31 $2,506,522 246,948
2021-12-31 $438,717 26,302
2021-09-30 $1,077,166 22,982
2021-06-30 $386,547 6,341
2021-03-31 $892,091 14,482
2020-12-31 $794,938 11,179
2020-09-30 $642,905 17,135
2020-06-30 $282,956 8,677
2020-03-31 $745,706 25,714